{
  "items": "42",
  "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish",
  "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.",
  "feed": [
    {
      "title": "Press Release: Bioceres Crop Solutions Reports Fiscal First Quarter 2026 Financial and Operational Results",
      "url": "https://news.futunn.com/en/post/64828083/press-release-bioceres-crop-solutions-reports-fiscal-first-quarter-2026",
      "time_published": "20251224T220854",
      "authors": [
        "NULL"
      ],
      "summary": "Bioceres Crop Solutions has reported its fiscal first-quarter 2026 financial and operational results. Separately, Unity Software (U.US) announced its fourth-quarter earnings, with revenue increasing 35% year-over-year to $609 million, surpassing consensus estimates, despite reporting a quarterly loss of 66 cents per share. The full details of Bioceres' report are not provided in this snippet.",
      "banner_image": "NULL",
      "source": "\u5bcc\u9014\u725b\u725b",
      "category_within_source": "General",
      "source_domain": "\u5bcc\u9014\u725b\u725b",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.907818"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.700858"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.640740"
        }
      ],
      "overall_sentiment_score": 0.111947,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.137513",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Given Consensus Rating of \"Hold\" by Analysts",
      "url": "https://www.marketbeat.com/instant-alerts/bioceres-crop-solutions-corp-nasdaqbiox-given-consensus-rating-of-hold-by-analysts-2025-12-17/",
      "time_published": "20251217T131023",
      "authors": [
        "MarketBeat"
      ],
      "summary": "Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has received a consensus \"Hold\" rating from five analysts, with three issuing a \"hold,\" one a \"sell,\" and one a \"buy\" recommendation. The average 12-month price target is $4.08, while shares currently trade around $1.51. Institutional ownership stands at approximately 17.7%, with several funds recently increasing their stakes.",
      "banner_image": "https://www.marketbeat.com/logos/bioceres-crop-solutions-corp-logo-1200x675.jpg?v=20240521154539",
      "source": "MarketBeat",
      "category_within_source": "General",
      "source_domain": "MarketBeat",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.949887"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.816683"
        }
      ],
      "overall_sentiment_score": 0.02378,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.020045",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Bioceres Crop Solutions (NASDAQ:BIOX) Stock Price Down 1.3% - Should You Sell?",
      "url": "https://www.marketbeat.com/instant-alerts/bioceres-crop-solutions-nasdaqbiox-stock-price-down-13-should-you-sell-2025-12-16/",
      "time_published": "20251216T080909",
      "authors": [
        "MarketBeat"
      ],
      "summary": "Shares of Bioceres Crop Solutions (NASDAQ:BIOX) fell by 1.3% on Monday, trading at $1.55 with an 87% increase in volume. The stock's 50-day moving average is below its 200-day average, signaling a downtrend, and analyst sentiment has weakened with several downgrades and a consensus \"Hold\" rating. The company's fundamentals currently show a market capitalization of $98.01 million, a negative trailing P/E of -1.85, and thin liquidity.",
      "banner_image": "https://www.marketbeat.com/logos/bioceres-crop-solutions-corp-logo-1200x675.jpg?v=20240521154539",
      "source": "MarketBeat",
      "category_within_source": "General",
      "source_domain": "MarketBeat",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "0.911662"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.807003"
        }
      ],
      "overall_sentiment_score": -0.406274,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.415211",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives Average Rating of \"Hold\" from Brokerages",
      "url": "https://www.marketbeat.com/instant-alerts/bioceres-crop-solutions-corp-nasdaqbiox-receives-average-rating-of-hold-from-brokerages-2025-11-22/",
      "time_published": "20251123T052216",
      "authors": [
        "MarketBeat"
      ],
      "summary": "Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has received an average rating of \"Hold\" from brokerage firms, with analysts issuing one sell, three hold, and one buy recommendation. The average 12-month price target is $4.0833. Recent adjustments include Lake Street trimming its target from $8 to $5 and Oppenheimer downgrading the stock to market perform.",
      "banner_image": "https://www.marketbeat.com/logos/bioceres-crop-solutions-corp-logo-1200x675.jpg?v=20240521154539",
      "source": "MarketBeat",
      "category_within_source": "General",
      "source_domain": "MarketBeat",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "0.942891"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.734020"
        },
        {
          "topic": "finance",
          "relevance_score": "0.621206"
        }
      ],
      "overall_sentiment_score": 0.046151,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.010070",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Is Bioceres Crop Solutions (NASDAQ:BIOX) A Risky Investment?",
      "url": "https://simplywall.st/stocks/us/materials/nasdaq-biox/bioceres-crop-solutions/news/is-bioceres-crop-solutions-nasdaqbiox-a-risky-investment",
      "time_published": "20251118T070725",
      "authors": [
        "Simply Wall St"
      ],
      "summary": "This article analyzes Bioceres Crop Solutions' debt levels, finding it to be a risky investment due to substantial debt, weak interest cover, and declining EBIT. While the company demonstrates strong free cash flow conversion, its overall financial health suggests a heavy debt load.",
      "banner_image": null,
      "source": "Simply Wall Street",
      "category_within_source": "General",
      "source_domain": "Simply Wall Street",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.934667"
        },
        {
          "topic": "finance",
          "relevance_score": "0.821391"
        }
      ],
      "overall_sentiment_score": -0.440765,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.418297",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Bioceres Crop Solutions (NASDAQ:BIOX) Posts Earnings Results, Misses Expectations By $0.08 EPS",
      "url": "https://www.marketbeat.com/instant-alerts/bioceres-crop-solutions-nasdaqbiox-posts-earnings-results-misses-expectations-by-008-eps-2025-11-12/",
      "time_published": "20251118T001005",
      "authors": [
        "MarketBeat"
      ],
      "summary": "Bioceres Crop Solutions (NASDAQ:BIOX) reported a quarterly EPS of ($0.12), missing the consensus estimate by $0.08. The company also showed negative financial metrics, including a negative return on equity of 14.72% and a negative net margin of 15.27%. Analysts have reduced price targets and institutional ownership stands at 17.68%.",
      "banner_image": "https://www.marketbeat.com/logos/bioceres-crop-solutions-corp-logo-1200x675.jpg?v=20240521154539",
      "source": "MarketBeat",
      "category_within_source": "General",
      "source_domain": "MarketBeat",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.915794"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.849647"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.636555"
        },
        {
          "topic": "finance",
          "relevance_score": "0.618785"
        }
      ],
      "overall_sentiment_score": -0.492232,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.489816",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Bioceres Crop Solutions Focuses On Margins Over Sales Growth",
      "url": "https://finimize.com/content/bioceres-crop-solutions-focuses-on-margins-over-sales-growth",
      "time_published": "20251117T052216",
      "authors": [
        "Finimize Newsroom"
      ],
      "summary": "Bioceres Crop Solutions reported a 17% drop in revenue but improved profits by shifting focus to higher-margin products, particularly outside Latin America. The company's gross margin increased to 47% and adjusted EBITDA jumped 61%, exceeding forecasts, as it prioritizes financial health. Analysts remain cautiously optimistic, with a median price target significantly above the current share price, signaling potential market reward for this profit-centric strategy.",
      "banner_image": "https://finimize.com/_next/image?url=https%3A%2F%2Ffinimize-img.imgix.net%2Fhttps%253A%252F%252Fchivas-assets.s3-eu-west-1.amazonaws.com%252Fstatic%252Fimages%252Ftag_reuters_com_2025_newsml_L1N3WO192_1068275464.jpeg%3Fixlib%3Dpython-3.1.2%26s%3Dbf38d22be22b07e9ce4fe362003b3b32&w=3840&q=75",
      "source": "Finimize",
      "category_within_source": "General",
      "source_domain": "Finimize",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.936839"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.720671"
        },
        {
          "topic": "finance",
          "relevance_score": "0.625409"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.624963"
        },
        {
          "topic": "economy_macro",
          "relevance_score": "0.649985"
        }
      ],
      "overall_sentiment_score": 0.389922,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.406479",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Bioceres Crop Solutions Reports Q1 2026 Financial Results Amid Strategic Transition",
      "url": "https://www.msn.com/en-us/money/topstocks/bioceres-crop-solutions-reports-q1-2026-financial-results-amid-strategic-transition/ar-AA1Qnz2z?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1",
      "time_published": "20251117T052216",
      "authors": [],
      "summary": "This article analyzes Bioceres Crop Solutions' Q1 2026 financial results, which reflect its ongoing strategic transition. The report emphasizes the company's performance during this period of significant change and outlines future directions.",
      "banner_image": null,
      "source": "MSN",
      "category_within_source": "General",
      "source_domain": "MSN",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.939990"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.742686"
        }
      ],
      "overall_sentiment_score": 0.111004,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.134372",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Bioceres Crop Solutions Reports Margin Expansion and Improved Profitability in Q1 FY2026",
      "url": "https://igrownews.com/bioceres-crop-solution-latest-news/",
      "time_published": "20251117T052216",
      "authors": [
        "Madison Hong"
      ],
      "summary": "Bioceres Crop Solutions reported Q1 FY2026 revenues of $77.5 million, a 17% decrease year-over-year, attributed to a strategic shift away from low-margin sales. Despite this, gross profit margins significantly improved to 47%, and operating profit surged by 200% to $7.1 million, demonstrating enhanced profitability and operational efficiency. The company's CEO, Federico Trucco, emphasized a continued focus on margin quality, cost discipline, and optimizing capital structure amidst a gradually normalizing market in Argentina.",
      "banner_image": "https://igrownews.com/wp-content/uploads/2024/11/bioceres-crop-solution-latest-news-scaled.jpg",
      "source": "iGrow News",
      "category_within_source": "General",
      "source_domain": "iGrow News",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.919498"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.725194"
        }
      ],
      "overall_sentiment_score": 0.419624,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.415452",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Canaccord Genuity Maintains Bioceres Crop Solutions (BIOX) Hold Recommendation",
      "url": "https://www.nasdaq.com/articles/canaccord-genuity-maintains-bioceres-crop-solutions-biox-hold-recommendation",
      "time_published": "20251114T190500",
      "authors": [
        "George Maybach for Fintel"
      ],
      "summary": "Canaccord Genuity has maintained a Hold recommendation for Bioceres Crop Solutions (BIOX). Analysts forecast a significant upside of 227.31% for the stock, with an average one-year price target of $5.48/share. Institutional ownership data shows an increase in the number of funds holding positions in BIOX, despite a slight decrease in total shares owned by institutions.",
      "banner_image": null,
      "source": "Nasdaq",
      "category_within_source": "General",
      "source_domain": "Nasdaq",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.935888"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.801665"
        },
        {
          "topic": "finance",
          "relevance_score": "0.701511"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.619908"
        }
      ],
      "overall_sentiment_score": 0.396128,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.426334",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Earnings call transcript: Bioceres Crop sees Q1 2025 revenue drop, stock dips",
      "url": "https://www.investing.com/news/transcripts/earnings-call-transcript-bioceres-crop-sees-q1-2025-revenue-drop-stock-dips-93CH-4355477",
      "time_published": "20251113T090300",
      "authors": [
        "Investing.com"
      ],
      "summary": "Bioceres Crop Solutions Corp (BIOX) reported a significant miss in Q1 2025 earnings and revenue, with EPS at -$0.1183 against an expected $0.03 and revenue of $77.5 million, missing forecasts by 26.19%. The company's stock initially fell but showed a slight premarket recovery despite a 17% year-over-year revenue decline, ongoing challenges in Latin American markets, and a dispute with noteholders. Bioceres highlighted improvements in gross margin and adjusted EBITDA, focusing on operational efficiency and a scalable seed business model.",
      "banner_image": "https://i-invdn-com.investing.com/news/World_News_8_800x533_L_1420026210.jpg",
      "source": "Investing.com",
      "category_within_source": "General",
      "source_domain": "Investing.com",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.916428"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.811059"
        }
      ],
      "overall_sentiment_score": -0.191841,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.438203",
          "ticker_sentiment_label": "Bearish"
        },
        {
          "ticker": "CTVA",
          "relevance_score": "0.620526",
          "ticker_sentiment_score": "0.132969",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Bioceres Crop Solutions Reports Q1 2026 Financial Results Amid Strategic Transition",
      "url": "https://www.tipranks.com/news/company-announcements/bioceres-crop-solutions-reports-q1-2026-financial-results-amid-strategic-transition",
      "time_published": "20251113T001126",
      "authors": [
        "TipRanks Auto-Generated Newsdesk"
      ],
      "summary": "Bioceres Crop Solutions (BIOX) reported its fiscal Q1 2026 financial results with a 17% decline in total revenues to $77.5 million, attributed to strategic reductions in low-margin sales and a seed model transition. Despite the revenue drop, the company improved its gross margin to 47% and saw significant improvements in operating profit and adjusted EBITDA due to cost discipline. The net loss widened to $7.5 million, and amid challenging market conditions in Argentina, the company is focused on enhancing its capital structure and financial flexibility.",
      "banner_image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_519600637-1-750x406.jpg",
      "source": "TipRanks",
      "category_within_source": "General",
      "source_domain": "TipRanks",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.947559"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.725218"
        }
      ],
      "overall_sentiment_score": 0.046374,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "0.300142",
          "ticker_sentiment_score": "0.018795",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Bioceres Crop (BIOX) Reports Q1 Loss, Lags Revenue Estimates",
      "url": "https://www.nasdaq.com/articles/bioceres-crop-biox-reports-q1-loss-lags-revenue-estimates",
      "time_published": "20251112T230932",
      "authors": [
        "Zacks Equity Research"
      ],
      "summary": "Bioceres Crop (BIOX) reported a Q1 loss of $0.12 per share, missing the Zacks Consensus Estimate of a $0.04 loss and lagging revenues estimates with $77.3 million against an expected $94.6 million. The company's shares have significantly underperformed the S&P 500 year-to-date, though its current Zacks Rank #2 (Buy) suggests potential for outperformance in the near future.",
      "banner_image": "NULL",
      "source": "Nasdaq",
      "category_within_source": "General",
      "source_domain": "Nasdaq",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.911312"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.828726"
        }
      ],
      "overall_sentiment_score": 0.028156,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "0.311944",
          "ticker_sentiment_score": "0.036573",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Stock Catapults 29% Though Its Price And Business Still Lag The Industry",
      "url": "https://simplywall.st/stocks/us/materials/nasdaq-biox/bioceres-crop-solutions/news/bioceres-crop-solutions-corp-nasdaqbiox-stock-catapults-29-t",
      "time_published": "20251111T001126",
      "authors": [
        "Simply Wall St"
      ],
      "summary": "Bioceres Crop Solutions Corp. (NASDAQ:BIOX) has seen its stock price jump 29% in the last month, but this follows a significant 72% drop over the past year. Despite the recent bounce, the company's price-to-sales ratio remains low compared to the Chemicals industry average, primarily due to declining revenue and slower projected growth than its peers. Investors appear to be factoring in limited future growth, contributing to its modest valuation.",
      "banner_image": "NULL",
      "source": "Simply Wall Street",
      "category_within_source": "General",
      "source_domain": "Simply Wall Street",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.917229"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.816265"
        },
        {
          "topic": "finance",
          "relevance_score": "0.719464"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.621946"
        },
        {
          "topic": "economy_macro",
          "relevance_score": "0.615550"
        }
      ],
      "overall_sentiment_score": -0.203293,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.206832",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "How Recent Developments Are Reshaping the Bioceres Crop Solutions Investment Story",
      "url": "https://finance.yahoo.com/news/recent-developments-reshaping-bioceres-crop-230536041.html",
      "time_published": "20251018T230536",
      "authors": [
        "Simply Wall St"
      ],
      "summary": "Bioceres Crop Solutions (BIOX) maintains an unchanged Fair Value Estimate of $4.17 per share despite recent developments. The company faces both optimistic analyst views driven by next-generation products and cautious sentiments due to the CFO's departure and near-term performance challenges. A new strategic alliance with the Colorado Wheat Research Foundation for HB4 wheat commercialization in the U.S. is highlighted as a significant development, while financial projections show minor adjustments in discount rate, revenue growth, and net profit margin.",
      "banner_image": null,
      "source": "Yahoo Finance",
      "category_within_source": "General",
      "source_domain": "Yahoo Finance",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.903612"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.845518"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.719042"
        },
        {
          "topic": "finance",
          "relevance_score": "0.602266"
        }
      ],
      "overall_sentiment_score": 0.040351,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "0.319084",
          "ticker_sentiment_score": "0.004272",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Powerhouse companies develop crucial tech to protect US food supply: 'We are building the foundation' - The Cool Down",
      "url": "https://www.thecooldown.com/sustainable-food/hb4-wheat-crop-solutions-corp-colorado/",
      "time_published": "20251016T211500",
      "authors": [
        "Kristen Carr"
      ],
      "summary": "Bioceres Crop Solutions Corp. has partnered with the Colorado Wheat Research Foundation to introduce its HB4 wheat technology in the United States, aiming to enhance wheat production and grower profitability amidst increasing drought conditions caused by climate change. This collaboration seeks to develop a next-generation wheat system that is more resilient to drought, ensuring a stable food supply and supporting global sustainability goals. Experts believe this proactive approach and diversified crop types are crucial for farmers to adapt to changing climate realities.",
      "banner_image": "https://www.thecooldown.com/wp-content/uploads/2025/10/HB4-wheatimage-recq5dXu1uRgKYygY-1.jpg?w=1920&h=800",
      "source": "The Cool Down",
      "category_within_source": "General",
      "source_domain": "The Cool Down",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.701080"
        },
        {
          "topic": "technology",
          "relevance_score": "0.610448"
        },
        {
          "topic": "economy_macro",
          "relevance_score": "0.413912"
        }
      ],
      "overall_sentiment_score": 0.032151,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "0.325115",
          "ticker_sentiment_score": "0.010708",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Bioceres Crop Solutions (NASDAQ:BIOX) Stock Price Up 28.6% \u2013 Still a Buy?",
      "url": "https://www.defenseworld.net/2025/10/16/bioceres-crop-solutions-nasdaqbiox-stock-price-up-28-6-still-a-buy.html",
      "time_published": "20251016T170147",
      "authors": [
        "Defense World Staff"
      ],
      "summary": "Bioceres Crop Solutions (NASDAQ:BIOX) stock has seen a 28.6% price increase. The article details the company's financial performance, including its market cap, P/E ratio, and debt-to-equity ratio, alongside recent adjustments in holdings by institutional investors. Bioceres Crop Solutions specializes in crop productivity solutions, offering seed traits, germplasms, and seed treatment packs.",
      "banner_image": "https://www.marketbeat.com/logos/bioceres-crop-solutions-corp-logo-1200x675.jpg?v=20240521154539",
      "source": "Defense World",
      "category_within_source": "General",
      "source_domain": "Defense World",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "0.933004"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.819961"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.715624"
        }
      ],
      "overall_sentiment_score": 0.043628,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "0.300638",
          "ticker_sentiment_score": "0.036437",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Bioceres Crop Solutions (NASDAQ:BIOX) Stock Price Up 28.6% - Still a Buy? - MarketBeat",
      "url": "https://www.marketbeat.com/instant-alerts/bioceres-crop-solutions-nasdaqbiox-stock-price-up-286-still-a-buy-2025-10-16/",
      "time_published": "20251016T055701",
      "authors": [
        "MarketBeat"
      ],
      "summary": "Bioceres Crop Solutions (NASDAQ:BIOX) stock saw a significant 28.6% surge in its share price during Wednesday's trading, closing at $1.98 with exceptionally high trading volume. Despite this increase, analysts hold mixed views, with a \"Hold\" consensus and a target price of $4.17, though one firm recently downgraded it to \"Sell.\" Institutional investors, including Fourth Sail Capital LP and Allianz Asset Management GmbH, have notably increased their stakes, indicating growing confidence among major shareholders.",
      "banner_image": "https://www.marketbeat.com/logos/bioceres-crop-solutions-corp-logo-1200x675.jpg?v=20240521154539",
      "source": "MarketBeat",
      "category_within_source": "General",
      "source_domain": "MarketBeat",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "1.000000"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.825829"
        }
      ],
      "overall_sentiment_score": 0.006893,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "0.328080",
          "ticker_sentiment_score": "0.032759",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Farmmi (NASDAQ:FAMI) vs. Bioceres Crop Solutions (NASDAQ:BIOX) Head-To-Head Analysis - Defense World",
      "url": "https://www.defenseworld.net/2025/10/15/farmmi-nasdaqfami-vs-bioceres-crop-solutions-nasdaqbiox-head-to-head-analysis.html",
      "time_published": "20251015T063423",
      "authors": [
        "Defense World Staff"
      ],
      "summary": "This article provides a head-to-head analysis of Farmmi (NASDAQ:FAMI) and Bioceres Crop Solutions (NASDAQ:BIOX), comparing their profitability, institutional and insider ownership, volatility, earnings, valuation, and analyst recommendations. Bioceres Crop Solutions appears more favorable based on analyst ratings and potential upside, despite Farmmi having higher earnings but lower revenue. The analysis aims to help investors make informed decisions between these two companies.",
      "banner_image": "https://www.defenseworld.net/2025/10/15/farmmi-nasdaqfami-vs-bioceres-crop-solutions-nasdaqbiox-head-to-head-analysis.html",
      "source": "Defense World",
      "category_within_source": "General",
      "source_domain": "Defense World",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.934487"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.807847"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.518118"
        },
        {
          "topic": "finance",
          "relevance_score": "0.424684"
        }
      ],
      "overall_sentiment_score": 0.040834,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "0.349809",
          "ticker_sentiment_score": "0.012162",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Bioceres Crop Solutions and Colorado Wheat Research Foundation Partner to Advance Climate-Resilient HB4\u00ae Wheat in the U.S.",
      "url": "https://www.aginfo.net/report/63606/Land-Livestock-Report/Bioceres-Crop-Solutions-and-Colorado-Wheat-Research-Foundation-Partner-to-Advance-Climate-Resilient-HB4-Wheat-in-the-U-S-",
      "time_published": "20250925T210937",
      "authors": [
        "Russell Nemetz"
      ],
      "summary": "Bioceres Crop Solutions and the Colorado Wheat Research Foundation (CWRF) have formed a strategic partnership to develop and commercialize HB4\u00ae wheat in the United States. This collaboration aims to integrate climate resilience and sustainable weed management into wheat production, enhancing grower productivity and supply stability. CWRF will manage the HB4\u00ae trait, ensuring broad access for breeding programs and leading stakeholder engagement, while Bioceres handles regulatory activities.",
      "banner_image": "https://www.aginfo.net/Assets/ReportImages/report_68d41d36377bb063319697_1920_1080.jpg",
      "source": "AG INFORMATION NETWORK OF THE WEST",
      "category_within_source": "General",
      "source_domain": "AG INFORMATION NETWORK OF THE WEST",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.819098"
        },
        {
          "topic": "manufacturing",
          "relevance_score": "0.749167"
        }
      ],
      "overall_sentiment_score": 0.418029,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.418141",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Earnings call transcript: Bioceres Crop Q4 2025 sees sharp revenue drop",
      "url": "https://www.investing.com/news/transcripts/earnings-call-transcript-bioceres-crop-q4-2025-sees-sharp-revenue-drop-93CH-4231652",
      "time_published": "20250909T101400",
      "authors": [
        "Investing.com"
      ],
      "summary": "Bioceres Crop Solutions (BIOX) reported a significant 40% decline in Q4 2025 revenues to $74.7 million, missing forecasts, leading to a nearly 15% pre-market stock drop. Despite annual revenues falling 28% due to challenges in the Argentine agricultural market and a strategic shift in its HB4 seed business to a royalty model, the company saw increased operating cash flow and aims for improved gross and EBITDA margins. Bioceres plans to achieve a 40% gross margin and 22% EBITDA margin through cost controls, reduced capital expenditures, and scaling biological initiatives in the U.S. and Brazil while addressing its $220.8 million net financial debt.",
      "banner_image": "https://i-invdn-com.investing.com/news/World_News_9_800x533_L_1420026261.jpg",
      "source": "Investing.com",
      "category_within_source": "General",
      "source_domain": "Investing.com",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "1.000000"
        },
        {
          "topic": "finance",
          "relevance_score": "0.741437"
        },
        {
          "topic": "economy_macro",
          "relevance_score": "0.639253"
        }
      ],
      "overall_sentiment_score": -0.747017,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.702851",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Agricultural Tech Leader Bioceres Crop Solutions to Present Full Year 2025 Results on September 9",
      "url": "https://www.stocktitan.net/news/BIOX/bioceres-crop-solutions-to-host-fiscal-fourth-quarter-and-full-year-et0hclbwqsl5.html",
      "time_published": "20250902T052216",
      "authors": [
        "NULL"
      ],
      "summary": "Bioceres Crop Solutions (NASDAQ: BIOX) will host a conference call on Tuesday, September 9, 2025, at 8:30 a.m. Eastern Time, to discuss its fiscal fourth quarter and full-year results for the period ended June 30, 2025. The call will feature Chairman & CEO Federico Trucco and Head of Investor Relations Paula Savanti, and a press release with the results will precede the event. Investors can access the webcast and replay information through the company's investor relations website.",
      "banner_image": "NULL",
      "source": "Stock Titan",
      "category_within_source": "General",
      "source_domain": "Stock Titan",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.920735"
        },
        {
          "topic": "finance",
          "relevance_score": "0.733551"
        }
      ],
      "overall_sentiment_score": 0.106489,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.114573",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Bioceres\u2019 GMO wheat is safe for production, US says",
      "url": "https://www.batimes.com.ar/news/economy/bioceres-gmo-wheat-is-safe-for-production-us-says.phtml",
      "time_published": "20240828T174500",
      "authors": [
        "James Grainger"
      ],
      "summary": "The US Department of Agriculture has approved Bioceres Crop Solutions' genetically modified HB4 wheat for production, deeming it safe and unlikely to pose pest threats. This decision marks a significant milestone as HB4 would be the first GMO crop directly consumed by humans, though full commercialization in the US will take several years. Argentina-based Bioceres has already secured approval for its drought-tolerant and herbicide-resistant wheat in Brazil, Paraguay, and Argentina.",
      "banner_image": null,
      "source": "Buenos Aires Times",
      "category_within_source": "General",
      "source_domain": "Buenos Aires Times",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.905405"
        },
        {
          "topic": "economy_macro",
          "relevance_score": "0.730833"
        }
      ],
      "overall_sentiment_score": 0.469946,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.490913",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Bioceres Crop Solutions Announces Brazil\u2019s Approval of New Generation Bio-Insecticide",
      "url": "https://www.seedworld.com/latam/2024/05/10/bioceres-crop-solutions-announces-brazils-approval-of-new-generation-bio-insecticide/",
      "time_published": "20240510T000000",
      "authors": [
        "Seed World Staff"
      ],
      "summary": "Bioceres Crop Solutions has received approval from Brazil\u2019s Ministry of Agriculture and Livestock for three new bio-insecticidal/bio-nematicidal solutions derived from inactivated cells of its proprietary Burkholderia platform. This approval marks a significant regulatory milestone in Brazil, which is a leading bio-control market. The company expects these products to be highly competitive and contribute significantly to its growth in the region.",
      "banner_image": null,
      "source": "Seed World",
      "category_within_source": "General",
      "source_domain": "Seed World",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.939825"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.702337"
        }
      ],
      "overall_sentiment_score": 0.716628,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.743297",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Bioceres HB4 wheat gains approval in Brazil",
      "url": "https://www.world-grain.com/articles/18191-bioceres-hb4-wheat-gains-approval-in-brazil",
      "time_published": "20230303T000000",
      "authors": [
        "By Arvin Donley"
      ],
      "summary": "Bioceres Crop Solutions Corp. announced that its HB4 Wheat has received full approval for commercialization and cultivation in Brazil, making it the second country after Argentina to clear the genetically modified variety. This approval completes the process for Bioceres' wheat target markets in Latin America and will facilitate the acceleration of collaboration with EMBRAPA to develop subtropical wheat varieties. The HB4 technology offers potential for double cropping and has shown significant yield increases in drought-affected environments.",
      "banner_image": null,
      "source": "World-Grain.com",
      "category_within_source": "General",
      "source_domain": "World-Grain.com",
      "topics": [
        {
          "topic": "economy_macro",
          "relevance_score": "0.730310"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.642002"
        }
      ],
      "overall_sentiment_score": 0.815254,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.824702",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "DRACO Capital Cuts Stake in Bioceres Crop Solutions Corp. (BIOX)",
      "url": "https://www.nasdaq.com/articles/draco-capital-cuts-stake-in-bioceres-crop-solutions-corp.-biox",
      "time_published": "20221120T184100",
      "authors": [
        "Fintel Staff"
      ],
      "summary": "DRACO Capital Investment Management Co Ltd significantly reduced its stake in Bioceres Crop Solutions Corp. (BIOX), decreasing its ownership from 13.50% to 0.34%. This report details the change in DRACO Capital's holdings, as well as the positions of other large institutional shareholders and the overall fund sentiment for BIOX. The article also provides a brief overview of Bioceres Crop Solutions Corp.'s business.",
      "banner_image": null,
      "source": "Nasdaq",
      "category_within_source": "General",
      "source_domain": "Nasdaq",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "0.917751"
        },
        {
          "topic": "finance",
          "relevance_score": "0.846330"
        }
      ],
      "overall_sentiment_score": -0.233292,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.200375",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "Drought-tolerant wheat trait clears one more hurdle in United States",
      "url": "https://www.farmprogress.com/crops/drought-tolerant-wheat-trait-clears-one-more-hurdle-in-united-states",
      "time_published": "20220706T161632",
      "authors": [
        "Jennifer M. Latzke"
      ],
      "summary": "The U.S. Food and Drug Administration has concluded its evaluation of the HB4 drought-tolerant wheat trait from Bioceres Crop Solutions, stating it has no further questions regarding its safety. This development marks a significant step towards commercialization, although the trait is not yet approved for planting in the U.S. The HB4 trait promises increased wheat yields in drought conditions and could offer a tool for carbon sequestration, benefiting farmers in arid regions.",
      "banner_image": null,
      "source": "Farm Progress",
      "category_within_source": "General",
      "source_domain": "Farm Progress",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.745714"
        }
      ],
      "overall_sentiment_score": 0.423246,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.430905",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "China Approves Drought Tolerant HB4\u00ae Soybeans",
      "url": "https://www.isaaa.org/kc/cropbiotechupdate/article/default.asp?ID=19441",
      "time_published": "20220504T161633",
      "authors": [],
      "summary": "China's Ministry of Agriculture has approved the import and use of Bioceres Crop Solutions Corp.'s HB4\u00ae drought-tolerant soybeans as a raw material. This approval, announced on April 29, 2022, follows confirmation from Bioceres' Chinese partner and paves the way for unrestricted growth and commercialization of HB4\u00ae soybeans in major agricultural regions. HB4\u00ae soybeans are now approved in countries representing approximately 85 percent of the global soybean trade.",
      "banner_image": null,
      "source": "ISAAA.org",
      "category_within_source": "General",
      "source_domain": "ISAAA.org",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.903025"
        }
      ],
      "overall_sentiment_score": 0.819456,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.811194",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Marrone Bio to sell for $236 million to Argentinian company Bioceres",
      "url": "https://www.bizjournals.com/sacramento/inno/stories/news/2022/03/16/marrone-bio-sale-bioceres.html",
      "time_published": "20220316T193200",
      "authors": [
        "Mark Anderson"
      ],
      "summary": "Bioceres Crop Solutions Corp. has agreed to acquire Marrone Bio Innovations Inc. for $236 million in an all-stock transaction. Marrone Bio Innovations, founded in Davis, will be purchased by the Argentinian company. The deal was reported on March 16, 2022.",
      "banner_image": null,
      "source": "The Business Journals",
      "category_within_source": "General",
      "source_domain": "The Business Journals",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "1.000000"
        }
      ],
      "overall_sentiment_score": 0.427982,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.405412",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Nueva regulaci\u00f3n en trazabilidad de alimentos impactar\u00eda mercado de EU",
      "url": "https://www.opportimes.com/mercados/nueva-regulacion-en-trazabilidad-de-alimentos-impactaria-mercado-de-eu/",
      "time_published": "20211126T194745",
      "authors": [
        "Redacci\u00f3n Opportimes"
      ],
      "summary": "A new FDA regulation on food traceability is projected to affect 20-30% of the U.S. food market, requiring end-to-end traceability records from supply chain participants. Bioceres Crop Solutions Corp. highlighted this regulation, noting that investments in food traceability technology could reach $19 billion by 2023, with blockchain playing a key role in ensuring transparency. The agricultural blockchain market is also expected to grow significantly, driven by consumer demand for product origin information and sustainable sourcing.",
      "banner_image": null,
      "source": "Opportimes",
      "category_within_source": "General",
      "source_domain": "Opportimes",
      "topics": [
        {
          "topic": "retail_wholesale",
          "relevance_score": "0.742334"
        },
        {
          "topic": "technology",
          "relevance_score": "0.640099"
        },
        {
          "topic": "blockchain",
          "relevance_score": "0.846068"
        }
      ],
      "overall_sentiment_score": 0.26718,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.256514",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Alimentos sostenibles: crece tendencia a favor en el mundo",
      "url": "https://www.opportimes.com/mercados/alimentos-sostenibles-crece-tendencia-a-favor-en-el-mundo/",
      "time_published": "20211115T194745",
      "authors": [
        "Redacci\u00f3n Opportimes"
      ],
      "summary": "The trend towards sustainable food is growing worldwide, driven by increasing consumer awareness of environmental issues and the desire for brands to \"do good.\" Younger generations, particularly Gen Z and Millennials, are more likely to prioritize and spend more on sustainable products, influencing the entire food system from raw materials to consumer choices. This shift is evident in rising Google searches for sustainability topics and increased demand for socially conscious meals.",
      "banner_image": null,
      "source": "Opportimes",
      "category_within_source": "General",
      "source_domain": "Opportimes",
      "topics": [
        {
          "topic": "retail_wholesale",
          "relevance_score": "0.818484"
        },
        {
          "topic": "economy_macro",
          "relevance_score": "0.721970"
        }
      ],
      "overall_sentiment_score": 0.414595,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.426168",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Canad\u00e1 aprueba la soja HB4 tolerante a estr\u00e9s h\u00eddrico desarrollada por la argentina Bioceres",
      "url": "https://agroempresario.com/publicacion/52720/canada-aprueba-la-soja-hb4-tolerante-a-estres-hidrico-desarrollada-por-la-argentina-bioceres/",
      "time_published": "20210603T194745",
      "authors": [],
      "summary": "Canada has approved Bioceres' HB4 drought-tolerant soy, marking a significant step for the Argentine company's agricultural technology. This approval expands the global footprint for HB4 soy, which is already sanctioned in other major producing nations like the US, Brazil, Argentina, and Paraguay. The expansion into Southern Canada aims to leverage the region's suitability and pioneering agricultural industry for identity-preserved production systems.",
      "banner_image": null,
      "source": "Agroempresario.com",
      "category_within_source": "General",
      "source_domain": "Agroempresario.com",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.932372"
        },
        {
          "topic": "economy_macro",
          "relevance_score": "0.707070"
        }
      ],
      "overall_sentiment_score": 0.427133,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "0.988937",
          "ticker_sentiment_score": "0.416273",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Canad\u00e1 aprob\u00f3 el cultivo de la soja HB4 argentina tolerante a la sequ\u00eda",
      "url": "https://elagrario.com/actualidad/canada-aprobo-el-cultivo-de-la-soja-hb4-argentina-tolerante-a-la-sequia-50799/",
      "time_published": "20210603T095500",
      "authors": [
        "Redacci\u00f3n El Agrario"
      ],
      "summary": "Canadian regulatory agencies have approved the HB4 soybean variety, developed by Bioceres and the National University of Litoral (UNL) in Argentina, which is tolerant to drought and herbicides. This approval will allow HB4 soybeans to expand into the Northern Hemisphere, targeting regions in Canada and the United States with significant soybean cultivation. HB4 soybeans already have approval in the US, Brazil, Paraguay, and Argentina, representing 85% of the global cultivation area, and are awaiting authorization for import in China.",
      "banner_image": null,
      "source": "El Agrario",
      "category_within_source": "General",
      "source_domain": "El Agrario",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.809234"
        },
        {
          "topic": "economy_macro",
          "relevance_score": "0.648562"
        }
      ],
      "overall_sentiment_score": 0.478095,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.471093",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Mercados en baja: el S&P Merval cay\u00f3 1,3% y los ADR descendieron hasta 3%",
      "url": "https://eleconomista.com.ar/economia/mercados-baja-s-p-merval-cayo-13-adr-descendieron-3-n43341",
      "time_published": "20210511T194745",
      "authors": [],
      "summary": "The S&P Merval index fell by 1.3% and Argentine ADRs dropped by up to 3%, following a negative trend in Wall Street. The risk country index also rose by 0.6%, exceeding 1,600 points, while the blue dollar lost gains. This decline was largely influenced by concerns about potential inflation and a more hawkish stance from the Federal Reserve.",
      "banner_image": null,
      "source": "El Economista: \u00daltimas noticias econ\u00f3micas y financieras",
      "category_within_source": "General",
      "source_domain": "El Economista: \u00daltimas noticias econ\u00f3micas y financieras",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "0.947079"
        },
        {
          "topic": "economy_monetary",
          "relevance_score": "0.739889"
        },
        {
          "topic": "economy_macro",
          "relevance_score": "0.638650"
        }
      ],
      "overall_sentiment_score": 0.017151,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "0.307476",
          "ticker_sentiment_score": "0.000272",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Bioceres CEO promotes GM wheat to combat food shortages",
      "url": "https://www.farmprogress.com/wheat/bioceres-ceo-promotes-gm-wheat-to-combat-food-shortages",
      "time_published": "20210426T194745",
      "authors": [
        "Jonathan Gilbert",
        "Scott Squires"
      ],
      "summary": "Bioceres CEO Federico Trucco advocates for genetically modified (GM) wheat to address impending global food shortages exacerbated by climate change and rising food prices. Despite past consumer and regulator resistance to biotech wheat, Bioceres hopes for approval in Brazil soon, which would be its first market. The company is also preparing to sell sustainability-linked bonds tied to carbon capture targets from its drought-resistant GM crops.",
      "banner_image": null,
      "source": "Farm Progress",
      "category_within_source": "General",
      "source_domain": "Farm Progress",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.844986"
        },
        {
          "topic": "finance",
          "relevance_score": "0.722816"
        },
        {
          "topic": "economy_macro",
          "relevance_score": "0.632914"
        }
      ],
      "overall_sentiment_score": 0.324281,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "0.999128",
          "ticker_sentiment_score": "0.328214",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Los ADR escalaron hasta 5%, siguiendo los pasos de la bolsa de Wall Street",
      "url": "https://eleconomista.com.ar/economia/los-adr-escalaron-5-siguiendo-pasos-bolsa-wall-street-n42408",
      "time_published": "20210401T194745",
      "authors": [],
      "summary": "ADRs rose by up to 5%, following positive movements on Wall Street for the second consecutive session. This surge was led by companies like Cresud, Despegar, Mercado Libre, and Bioceres Crop Solutions Corp, while some, like Telecom and Banco Macro, experienced declines. The Wall Street indices, particularly the Dow Jones, S&P 500, and Nasdaq, also saw gains, driven by optimism for a rapid US economic recovery due to widespread vaccination and a new stimulus package.",
      "banner_image": null,
      "source": "El Economista: \u00daltimas noticias econ\u00f3micas y financieras",
      "category_within_source": "General",
      "source_domain": "El Economista: \u00daltimas noticias econ\u00f3micas y financieras",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "1.000000"
        },
        {
          "topic": "economy_macro",
          "relevance_score": "0.843045"
        },
        {
          "topic": "economy_fiscal",
          "relevance_score": "0.747298"
        },
        {
          "topic": "technology",
          "relevance_score": "0.605429"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.626415"
        }
      ],
      "overall_sentiment_score": 0.290038,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.326493",
          "ticker_sentiment_label": "Somewhat-Bullish"
        },
        {
          "ticker": "C",
          "relevance_score": "0.608493",
          "ticker_sentiment_score": "0.306740",
          "ticker_sentiment_label": "Somewhat-Bullish"
        },
        {
          "ticker": "JPM",
          "relevance_score": "0.646304",
          "ticker_sentiment_score": "0.129191",
          "ticker_sentiment_label": "Neutral"
        },
        {
          "ticker": "MS",
          "relevance_score": "0.638263",
          "ticker_sentiment_score": "0.306003",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Rizobacter, subsidiaria de Bioceres, complet\u00f3 oferta de bonos",
      "url": "https://www.iprofesional.com/negocios/334507-rizobacter-subsidiaria-de-bioceres-completo-oferta-de-bonos",
      "time_published": "20210304T154400",
      "authors": [
        "iProfesional"
      ],
      "summary": "Rizobacter Argentina, a subsidiary of Bioceres Crop Solutions Corp., successfully completed a public offering of Series V corporate bonds, raising $26 million. The funds will be used for working capital, extending debt maturities, and reducing financing costs. Enrique L\u00f3pez Lecube, CFO of Bioceres, highlighted that this issuance aligns with their strategy to strengthen liquidity and fund HB4 generation efforts and global expansion of key biological products.",
      "banner_image": null,
      "source": "iProfesional",
      "category_within_source": "General",
      "source_domain": "iProfesional",
      "topics": [
        {
          "topic": "finance",
          "relevance_score": "0.918932"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.813032"
        }
      ],
      "overall_sentiment_score": 0.443028,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.430983",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Soja HB4\u00ae\ufe0f: con un acuerdo internacional, Bioceres apuesta de lleno a la inteligencia artificial para desarrollar variedades",
      "url": "https://www.infocampo.com.ar/soja-hb4%EF%B8%8F-con-un-acuerdo-internacional-bioceres-apuesta-de-lleno-a-la-inteligencia-artificial-desarrollar-variedades/",
      "time_published": "20210202T194745",
      "authors": [
        "Por Infocampo"
      ],
      "summary": "Bioceres Crop Solutions Corp and Nature Source Improved Plants (NSIP) have announced an agreement to establish an accelerated HB4\u00ae\ufe0f soybean breeding program in the United States, leveraging NSIP's advanced analytics and predictive breeding expertise. This partnership aims to develop drought-tolerant HB4 varieties more efficiently and rapidly, reducing testing and development costs. The collaboration will also help Bioceres target a wider range of drought-prone regions globally and bring products to market faster.",
      "banner_image": null,
      "source": "Infocampo",
      "category_within_source": "General",
      "source_domain": "Infocampo",
      "topics": [
        {
          "topic": "technology",
          "relevance_score": "0.815014"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.738170"
        }
      ],
      "overall_sentiment_score": 0.414483,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.400329",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Bioceres usa inteligencia artificial para desarrollo de soja HB4",
      "url": "https://www.iprofesional.com/negocios/332622-bioceres-usa-inteligencia-artificial-para-desarrollo-de-soja-hb4",
      "time_published": "20210202T172300",
      "authors": [
        "iProfesional"
      ],
      "summary": "Bioceres Crop Solutions Corp. has partnered with Nature Source Improved Plants (NSIP) to accelerate the development of HB4 soybean varieties in the United States using advanced AI and predictive breeding technologies. This collaboration aims to enhance research, mapping, and prioritization of drought-prone cultivation areas, leading to faster market introduction of HB4 varieties and stronger commercial partnerships. The initiative is expected to reduce testing and development costs while expanding the reach of Bioceres' patented drought-tolerance technology globally.",
      "banner_image": null,
      "source": "iProfesional",
      "category_within_source": "General",
      "source_domain": "iProfesional",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.909815"
        },
        {
          "topic": "technology",
          "relevance_score": "0.818721"
        }
      ],
      "overall_sentiment_score": 0.436781,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.445730",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Nueva era en Brasil: aprueban la comercializaci\u00f3n de la soja HB4",
      "url": "https://www.clarin.com/rural/nueva-brasil-aprueban-comercializacion-soja-hb4_0_krNAqzalu.html",
      "time_published": "20190524T235226",
      "authors": [
        "Redacci\u00f3n Clar\u00edn"
      ],
      "summary": "Brazil has approved the commercialization of HB4 soybean technology, which provides drought tolerance. This approval for the HB4 event alone and in a stack with herbicide tolerance technology marks a significant step for Verdeca and TMG, allowing initial plantings and harvests in Brazil. The technology aims to reduce yield losses for farmers in drought-prone regions, with full commercial launch awaiting approvals from major importing countries.",
      "banner_image": null,
      "source": "Clarin.com",
      "category_within_source": "General",
      "source_domain": "Clarin.com",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.803967"
        },
        {
          "topic": "economy_macro",
          "relevance_score": "0.740860"
        }
      ],
      "overall_sentiment_score": 0.416994,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.436781",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Bioceres Argentina SA complet\u00f3 el lanzamiento de Bioceres Crop Solutions Corp. en la Bolsa de Nueva York",
      "url": "https://abogados.com.ar/bioceres-argentina-sa-completo-el-lanzamiento-de-bioceres-crop-solutions-corp-en-la-bolsa-de-nueva-york/23196",
      "time_published": "20190404T235226",
      "authors": [],
      "summary": "Marval, O\u2019Farrell & Mairal asesor\u00f3 a Bioceres Argentina SA en la combinaci\u00f3n de negocios de su subsidiaria Bioceres LLC con Union Acquisition Corp., resultando en Bioceres Crop Solutions Corp. La compa\u00f1\u00eda combinada comenz\u00f3 a cotizar en la Bolsa de Nueva York el 15 de marzo de 2019 bajo los s\u00edmbolos \"BIOX\" y \"BIOX WS\", con un valor inicial anticipado de USD 456 millones. Este hito convierte a Bioceres en la primera compa\u00f1\u00eda de biotecnolog\u00eda de Am\u00e9rica Latina en cotizar en la NYSE.",
      "banner_image": null,
      "source": "Abogados.com.ar",
      "category_within_source": "General",
      "source_domain": "Abogados.com.ar",
      "topics": [
        {
          "topic": "ipo",
          "relevance_score": "1.000000"
        },
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.901126"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.822917"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.713543"
        }
      ],
      "overall_sentiment_score": 0.413888,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.448602",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Con nuevo nombre, Bioceres ya es la due\u00f1a del 80% de Rizobacter",
      "url": "https://www.lavoz.com.ar/agro/actualidad/con-nuevo-nombre-bioceres-ya-es-duena-del-80-de-rizobacter/",
      "time_published": "20190319T101300",
      "authors": [
        "Redacci\u00f3n Agrovoz"
      ],
      "summary": "Bioceres SA announced its business combination with Union Acquisition Corp., changing its name to Bioceres Crop Solutions Corp. With this move, Bioceres Crop Solutions Corp. has increased its stake in Rizobacter Argentina SA from 50.01 percent to 80 percent. The company also reported significant financial growth for the three months ending December 31, with sales up 33 percent and EBITDA soaring by 121 percent.",
      "banner_image": null,
      "source": "La Voz del Interior",
      "category_within_source": "General",
      "source_domain": "La Voz del Interior",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.913145"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.841711"
        }
      ],
      "overall_sentiment_score": 0.403945,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "BIOX",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.416452",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    }
  ]
}